Using music and auditory beat stimulation to reduce anxiety
Music and Auditory Beat Stimulation and Its Effect on Anxiety
This study is testing if combining calming music with special sound beats can help young adults with anxiety feel less anxious compared to just listening to white noise.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 30 Years |
| Sex | All |
| Sponsor | Toronto Metropolitan University Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Trial ID | NCT05442086 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of combining calm music with theta auditory beat stimulation (ABS) as a treatment for anxiety in young adults. Participants aged 18-30 with generalized anxiety will be randomly assigned to receive either the combined treatment or a control condition of pink noise. The study will measure various psychophysiological indicators, including heart rate variability, EEG, and salivary cortisol, alongside subjective anxiety assessments. The goal is to determine if the combination of music and ABS leads to greater reductions in anxiety compared to the control.
Who should consider this trial
Good fit: Ideal candidates are undergraduate students aged 18-30 with a GAD-2 score of 1 or higher indicating generalized anxiety.
Not a fit: Patients with a history of cardiovascular conditions or seizures may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could provide a non-invasive and accessible method for reducing anxiety in young adults.
How similar studies have performed: Previous studies have shown that both music and auditory beat stimulation can reduce anxiety, suggesting potential success for this combined approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * GAD-2 score of 1 or higher indicating generalized anxiety. * Age between 18-30 years * Undergraduate student * Comfortable speaking and understanding English * Self-reported normal hearing Exclusion Criteria: * Self-reported history of cardiovascular conditions (e.g., arrhythmia, heart disease) * History of seizures or epilepsy
Where this trial is running
Toronto, Ontario
- Toronto Metropolitan University — Toronto, Ontario, Canada (Recruiting)
Study contacts
- Principal investigator: Frank Russo, PhD — Toronto Metropolitan University (formerly Ryerson University)
- Study coordinator: Adiel Mallik, PhD
- Email: adiel.mallik@ryerson.ca
- Phone: 416-979-5000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.